{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:58:24Z","timestamp":1781179104511,"version":"3.54.1"},"reference-count":26,"publisher":"Scientific Scholar","issue":"04","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":119,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, significantly increases the risk of colitis-associated cancer (CAC). Chronic inflammation, a key contributor to carcinogenesis, disrupts immune surveillance, induces deoxyribonucleic acid (DNA) damage, and alters genetic and epigenetic pathways. Molecular pathways such as STAT3, mTOR, and NF-\u03baB drive CAC progression, while unique microbiome alterations\u2014loss of Faecalibacterium prausnitzii and increases in Escherichia coli and Fusobacterium species\u2014exacerbate the inflammatory milieu. CAC accounts for 2% of all colon cancers and up to 15% of IBD-related deaths. Risk correlates with IBD duration, increasing approximately 1% annually after the first decade. Surveillance via colonoscopy is crucial, with chromoendoscopy recommended for high-risk cases. Preventive drugs, including aminosalicylates, thiopurines, and biologics, offer modest benefits but lack conclusive evidence. Post-CAC diagnosis, immunosuppressants are discontinued in favor of corticosteroids, with 5-aminosalicylates continued as needed. The use of immune checkpoint inhibitors remains controversial due to exacerbation of colitis. Emerging insights into the gut microbiota's role in IBD and CAC may revolutionize prevention and management strategies. Advances in screening, surveillance, and therapeutic approaches have reduced CAC mortality, underscoring the importance of personalized medicine and ongoing research to address these complex conditions.<\/jats:p>","DOI":"10.1055\/s-0045-1802335","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T20:14:53Z","timestamp":1738095293000},"page":"300-304","source":"Crossref","is-referenced-by-count":1,"title":["Inflammatory Bowel Disease and Colorectal Cancer: An Eternal Fire in a Beautiful Garden"],"prefix":"10.25259","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3968-8354","authenticated-orcid":false,"given":"Venkata Pradeep Babu","family":"Koyyala","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Shankara Cancer and Research Institute, Tezpur, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Kantharia","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Nanavati Super Specialty Hospital, Mumbai, Maharashtra, India"},{"name":"Department of Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naitica","family":"Darooka","sequence":"additional","affiliation":[{"name":"Department of Medicine, KEM Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandhir","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrihari","family":"Anikhindi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh Kumar","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dr. V.P.","family":"Bhalla","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, PSRI Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cloud Physician, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Fortis Hospital, Faridabad, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Abrol","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, American Oncology Institute, Jammu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peush","family":"Sahni","sequence":"additional","affiliation":[{"name":"Department of Surgical Gasteroenterology, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Ardhanari","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Meenakshi Mission Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pradeep","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suviraj","family":"John","sequence":"additional","affiliation":[{"name":"Minimal Access Surgery Department, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumitra","family":"Rawat","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvish","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, Sri Ram Cancer Center, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Selvasekar","sequence":"additional","affiliation":[{"name":"Divisional Medical Director, Clinical Services & Specialist Surgery, The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.18632\/oncotarget.12739","article-title":"The concept of immune surveillance against tumors. The first theories","volume":"8","author":"D Ribatti","year":"2017","journal-title":"Oncotarget"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00000441-192508010-00006","article-title":"Sigmoidoscopic picture of chronic ulcerative colitis.","volume":"170","author":"B B Crohn","year":"1925","journal-title":"Am J Med Sci"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2013.07.024","article-title":"Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis","volume":"12","author":"L K Wanders","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"J A Eaden","year":"2001","journal-title":"Gut"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1053\/j.gastro.2006.03.028","article-title":"Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study","volume":"130","author":"F S Velayos","year":"2006","journal-title":"Gastroenterology"},{"issue":"08","key":"ref6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease","volume":"23","author":"C Canavan","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6917","key":"ref7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"L M Coussens","year":"2002","journal-title":"Nature"},{"issue":"7203","key":"ref8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"A Mantovani","year":"2008","journal-title":"Nature"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"D Hanahan","year":"2000","journal-title":"Cell"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0016-5085(90)90290-H","article-title":"A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice","volume":"98","author":"I Okayasu","year":"1990","journal-title":"Gastroenterology"},{"issue":"09","key":"ref11","first-page":"1839","article-title":"First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of \u201cwestern\u201d disease","volume":"19","author":"J Zhao","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1053\/j.gastro.2007.09.008","article-title":"Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors","volume":"133","author":"M Fukata","year":"2007","journal-title":"Gastroenterology"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ijc.25430","article-title":"Cancer inflammation and regulatory T cells","volume":"127","author":"S E Erdman","year":"2010","journal-title":"Int J Cancer"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/j.gastro.2015.12.036","article-title":"Whole-exome sequencing analyses of inflammatory bowel disease: associated colorectal cancers","volume":"150","author":"A I Robles","year":"2016","journal-title":"Gastroenterology"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.gastro.2012.04.054","article-title":"Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010","volume":"143","author":"L J Herrinton","year":"2012","journal-title":"Gastroenterology"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ajg.2011.50","article-title":"5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study","volume":"106","author":"C N Bernstein","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"09","key":"ref17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2012.198","article-title":"5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations","volume":"107","author":"G C Nguyen","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease","volume":"177","author":"B Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.gastro.2021.05.063","article-title":"AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review","volume":"161","author":"S K Murthy","year":"2021","journal-title":"Gastroenterology"},{"key":"ref20","first-page":"359","article-title":"Management of inflammatory bowel disease in poor responders to infliximab","volume":"7","author":"I Guerra","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-0037-1602237","article-title":"Colorectal cancer in inflammatory bowel disease","volume":"31","author":"R W Stidham","year":"2018","journal-title":"Clin Colon Rectal Surg"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamaoncol.2015.4368","article-title":"Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders","volume":"2","author":"D B Johnson","year":"2016","journal-title":"JAMA Oncol"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1200\/JCO.19.01674","article-title":"Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease","volume":"38","author":"H Abu-Sbeih","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S1405","DOI":"10.1016\/j.annonc.2021.10.094","article-title":"76P Need for awareness about immune-related adverse events (iRAEs) among community physicians in India","volume":"32","author":"V P Koyyala","year":"2021","journal-title":"Ann Oncol"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"e39743","DOI":"10.1371\/journal.pone.0039743","article-title":"Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer","volume":"7","author":"W Chen","year":"2012","journal-title":"PLoS One"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MIB.0000000000000590","article-title":"Changes in the abundance of Faecalibacterium prausnitzii phylogroups I and II in the intestinal mucosa of inflammatory bowel disease and patients with colorectal cancer","volume":"22","author":"M Lopez-Siles","year":"2016","journal-title":"Inflamm Bowel Dis"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1802335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:59Z","timestamp":1781176379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/inflammatory-bowel-disease-and-colorectal-cancer-an-eternal-fire-in-a-beautiful-garden\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":26,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,3,7]]},"published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0045-1802335","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}